• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Director Im Lisa sold $587,818 worth of shares (180,867 units at $3.25), decreasing direct ownership by 13% to 1,229,413 units (SEC Form 4)

    6/4/25 4:34:05 PM ET
    $PHLT
    Other Consumer Services
    Consumer Discretionary
    Get the next $PHLT alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
    X
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Im Lisa

    (Last) (First) (Middle)
    4309 HACIENDA DR SUITE 110

    (Street)
    PLEASANTON CA 94588

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Performant Healthcare Inc [ PHLT ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    06/03/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock, par value $0.0001 per share 06/03/2025 S 180,867 D $3.25 1,229,413 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    Remarks:
    /s/ Rohit Ramchandani, Attorney-in-Fact for Lisa C. Im 06/04/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $PHLT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $PHLT

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $PHLT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Performant to Participate in B Riley Securities' 25th Annual Institutional Investor Conference

      Performant Healthcare, Inc. (NASDAQ:PHLT) ("Performant"), a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, announced today that it will participate in the B Riley Securities 25th Annual Institutional Investor Conference on Wednesday May 21st: Performant's Chief Financial Officer, Rohit Ramchandani, will participate in one-on-one meetings to discuss the company's recently increased guidance, continued momentum in the commercial market, and the potential impact of policy shifts under the new administration. To schedule a meeting, please contact Performant or your B Riley representative. ABOUT PERFORMANT Performant supports healthcare

      5/14/25 10:00:00 AM ET
      $PHLT
      Other Consumer Services
      Consumer Discretionary
    • Performant Healthcare, Inc. Announces Financial Results for First Quarter 2025

      Performant Healthcare, Inc. (NASDAQ:PHLT), a leading provider of healthcare payment integrity services, today reported the following financial results for its first quarter ended March 31, 2025: First Quarter 2025 Financial Highlights Total revenue of $33.3 million, compared to total revenue of $27.3 million in the prior year period. Healthcare revenue of $33.2 million, compared to $25.8 million in the prior year period, an increase of approximately 29%. Net loss of $0.1 million, or $0.00 per diluted share, compared to net loss of $4.0 million, or $(0.05) per diluted share, in the prior year period. Adjusted EBITDA of $3.3 million, compared to $(1.2) million in the prior year perio

      5/8/25 4:00:00 PM ET
      $PHLT
      Other Consumer Services
      Consumer Discretionary
    • Performant Healthcare, Inc. to Report First Quarter 2025 Earnings on May 8, 2025

      Performant Healthcare, Inc. (NASDAQ:PHLT) (the "Company", "Performant"), a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, announced today that the company will report its first quarter 2025 results after the market closes Thursday May 8, 2025. The Company will also hold a conference call to discuss results at 5:00 pm (Eastern Time) that day. To join the conference call: Dial in 800-717-1738 or 646-307-1865, or Live webcast through company's website here Replay can be found approximately three hours after the call on the company website under the Events & Presentations section or by dialing 844-512-2921 (domestic), or 412-317-6671 (

      4/24/25 1:00:00 PM ET
      $PHLT
      Other Consumer Services
      Consumer Discretionary

    $PHLT
    Financials

    Live finance-specific insights

    See more
    • Performant Healthcare, Inc. Announces Financial Results for First Quarter 2025

      Performant Healthcare, Inc. (NASDAQ:PHLT), a leading provider of healthcare payment integrity services, today reported the following financial results for its first quarter ended March 31, 2025: First Quarter 2025 Financial Highlights Total revenue of $33.3 million, compared to total revenue of $27.3 million in the prior year period. Healthcare revenue of $33.2 million, compared to $25.8 million in the prior year period, an increase of approximately 29%. Net loss of $0.1 million, or $0.00 per diluted share, compared to net loss of $4.0 million, or $(0.05) per diluted share, in the prior year period. Adjusted EBITDA of $3.3 million, compared to $(1.2) million in the prior year perio

      5/8/25 4:00:00 PM ET
      $PHLT
      Other Consumer Services
      Consumer Discretionary
    • Performant Healthcare, Inc. to Report First Quarter 2025 Earnings on May 8, 2025

      Performant Healthcare, Inc. (NASDAQ:PHLT) (the "Company", "Performant"), a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, announced today that the company will report its first quarter 2025 results after the market closes Thursday May 8, 2025. The Company will also hold a conference call to discuss results at 5:00 pm (Eastern Time) that day. To join the conference call: Dial in 800-717-1738 or 646-307-1865, or Live webcast through company's website here Replay can be found approximately three hours after the call on the company website under the Events & Presentations section or by dialing 844-512-2921 (domestic), or 412-317-6671 (

      4/24/25 1:00:00 PM ET
      $PHLT
      Other Consumer Services
      Consumer Discretionary
    • Performant Healthcare, Inc. Announces Financial Results for Fourth Quarter and Full Year 2024

      Performant Healthcare, Inc. (NASDAQ:PHLT), a leading provider of healthcare payment integrity services, today reported the following financial results for its fourth quarter and full year ended December 31, 2024: Fourth Quarter 2024 Financial Highlights Total revenues of $34.8 million, compared to $32.6 million in the prior year period Healthcare revenues of $34.3 million, compared to $31.1 million in the prior year period Net loss of $0.5 million, or $(0.01) per diluted share, compared to net income of $1.3 million, or $0.02 per diluted share, in the prior year period Adjusted EBITDA of $3.1 million, compared to $4.5 million in the prior year period Adjusted net income of $1.3 m

      3/12/25 4:00:00 PM ET
      $PHLT
      Other Consumer Services
      Consumer Discretionary

    $PHLT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Im Lisa sold $587,818 worth of shares (180,867 units at $3.25), decreasing direct ownership by 13% to 1,229,413 units (SEC Form 4)

      4 - Performant Healthcare Inc (0001550695) (Issuer)

      6/4/25 4:34:05 PM ET
      $PHLT
      Other Consumer Services
      Consumer Discretionary
    • Chief Financial Officer Ramchandani Rohit converted options into 40,202 shares and covered exercise/tax liability with 17,963 shares, increasing direct ownership by 11% to 233,515 units (SEC Form 4)

      4 - Performant Healthcare Inc (0001550695) (Issuer)

      5/16/25 3:56:03 PM ET
      $PHLT
      Other Consumer Services
      Consumer Discretionary
    • Chief Executive Officer Kohl Simeon converted options into 70,862 shares and covered exercise/tax liability with 25,759 shares, increasing direct ownership by 11% to 469,927 units (SEC Form 4)

      4 - Performant Healthcare Inc (0001550695) (Issuer)

      5/16/25 3:38:24 PM ET
      $PHLT
      Other Consumer Services
      Consumer Discretionary

    $PHLT
    SEC Filings

    See more
    • SEC Form 10-Q filed by Performant Healthcare Inc.

      10-Q - Performant Healthcare Inc (0001550695) (Filer)

      5/9/25 5:15:15 PM ET
      $PHLT
      Other Consumer Services
      Consumer Discretionary
    • Performant Healthcare Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Performant Healthcare Inc (0001550695) (Filer)

      5/8/25 4:13:01 PM ET
      $PHLT
      Other Consumer Services
      Consumer Discretionary
    • SEC Form DEFA14A filed by Performant Healthcare Inc.

      DEFA14A - Performant Healthcare Inc (0001550695) (Filer)

      4/25/25 8:24:54 PM ET
      $PHLT
      Other Consumer Services
      Consumer Discretionary